UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modelling NAFLD disease burden in four Asian regions—2019‐2030

Alimentary pharmacology & therapeutics, 2020-04, Vol.51 (8), p.801-811

2020

Volltextzugriff (PDF)

Treatment of chronic hepatitis C in Asia: When East meets West

Journal of gastroenterology and hepatology, 2009-03, Vol.24 (3), p.336-345

2009

Volltextzugriff (PDF)

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Journal of hepatology, 2018-04, Vol.68 (4), p.672-681

2018

Volltextzugriff (PDF)

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

The Journal of infectious diseases, 2021-12, Vol.224 (11), p.1890-1899

2021

Volltextzugriff (PDF)

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Hepatology international, 2020-09, Vol.14 (5), p.690-700

2020

Volltextzugriff (PDF)

Editorial: PNPLA3 genotype and liver diseases—more than non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2020-07, Vol.52 (2), p.390-391

2020

Volltextzugriff (PDF)

Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue

Liver international, 2018-03, Vol.38 (3), p.503-514

2018

Volltextzugriff (PDF)

2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations

Journal of the Formosan Medical Association, 2020-07, Vol.119 (7), p.1135-1157

2020

Volltextzugriff (PDF)

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020

The Kaohsiung journal of medical sciences, 2021-01, Vol.37 (1), p.7-11

2021

Volltextzugriff (PDF)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases

International journal of molecular sciences, 2020-05, Vol.21 (10), p.3732

2020

Volltextzugriff (PDF)

Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease

Journal of gastroenterology and hepatology, 2024-09, Vol.39 (9), p.1939-1949

2024

Volltextzugriff (PDF)

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Hepatology international, 2012-06, Vol.6 (3), p.531-561

2012

Volltextzugriff (PDF)

Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

The American journal of gastroenterology, 2024-03, Vol.119 (3), p.486-496

2024

Volltextzugriff (PDF)

Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma

Journal of translational medicine, 2024-03, Vol.22 (1), p.268-14, Article 268

2024

Volltextzugriff (PDF)

Impact of interleukin‐1β single nucleotide polymorphisms and depressive symptoms in individuals with chronic viral hepatitis

The Kaohsiung journal of medical sciences, 2024-01, Vol.40 (1), p.94-104

2024

Volltextzugriff (PDF)

Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter

Hepatology (Baltimore, Md.), 2020-08, Vol.72 (2), p.781-781

2020

Volltextzugriff (PDF)

Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response

Alimentary pharmacology & therapeutics, 2024-03, Vol.59 (6), p.742-751

2024

Volltextzugriff (PDF)

Role of interleukin‐28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

Hepatology (Baltimore, Md.), 2011-01, Vol.53 (1), p.7-13

2011

Volltextzugriff (PDF)

Cancer-associated fibroblasts up-regulate CCL2 , CCL26 , IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells

Biomedicine & pharmacotherapy, 2012-10, Vol.66 (7), p.525-529

2012

Volltextzugriff (PDF)

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues

Scientific reports, 2021-04, Vol.11 (1), p.8184-7, Article 8184

2021

Volltextzugriff (PDF)

Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells

Biomedicine & pharmacotherapy, 2012-09, Vol.66 (6), p.454-458

2012

Volltextzugriff (PDF)

Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma

Biomedicine & pharmacotherapy, 2022-09, Vol.153, p.113540-113540, Article 113540

2022

Volltextzugriff (PDF)

The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area

Journal of gastroenterology and hepatology, 2024-01, Vol.39 (1), p.193-201

2024

Volltextzugriff (PDF)

Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence

Liver international, 2021-05, Vol.41 (5), p.956-968

2021

Volltextzugriff (PDF)

Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment

Clinical cancer research, 2017-04, Vol.23 (7), p.1690-1697

2017

Volltextzugriff (PDF)

1 – 25 von 767

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(719)
Mit Volltextzugriff
(687)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(516)
Life Sciences & Biomedicine
(440)
Humans
(394)
Female
(304)
Male
(302)
Middle Aged
(259)
Adult
(224)
Gastroenterology & Hepatology
(209)
Aged
(156)
Hepatitis C
(135)
Hepatitis C Virus
(133)
Antiviral Agents - Therapeutic Use
(123)
Hepatitis C, Chronic - Drug Therapy
(117)
Hepatitis
(106)
Biological And Medical Sciences
(104)
Medical Sciences
(102)
Patients
(91)
Treatment Outcome
(86)
Hepatocellular Carcinoma
(83)
Medicine, Research & Experimental
(82)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Modelling NAFLD disease burden in four Asian regions—2019‐2030

Treatment of chronic hepatitis C in Asia: When East meets West

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Editorial: PNPLA3 genotype and liver diseases—more than non‐alcoholic fatty liver disease

Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue

2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases

Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

Systematic integration of molecular and clinical approaches in HCV-induced hepatocellular carcinoma

Impact of interleukin‐1β single nucleotide polymorphisms and depressive symptoms in individuals with chronic viral hepatitis

Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter

Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response

Role of interleukin‐28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

Cancer-associated fibroblasts up-regulate CCL2 , CCL26 , IL6 and LOXL2 genes related to promotion of cancer progression in hepatocellular carcinoma cells

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues

Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells

Advantage of clinical colchicine concentration to promote sorafenib or regorafenib anti-cancer effects on hepatocellular carcinoma

The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area

Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence

Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment

Suchergebnisse filtern